Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levoketoconazole in Endogenous Cushing's Syndrome (LOGICS)
NCT03277690Phase 3Completed
- Sponsor
- Strongbridge Biopharma
- Start
- Sep 2017
- Primary completion
- Jun 2020
- Countries
- 12
01
Overview
A Phase 3 trial of levoketoconazole in Cushing's syndrome, sponsored by Strongbridge Biopharma. Started Sep 2017; status: completed.
02
Drugs
levoketoconazole
03
Conditions
Cushing's syndrome
Beyond the preview
Go deeper on NCT03277690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03277690.